Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Egbring

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Pharmacoepidemiology and Drug Safety|September 25, 2009
Phynx: an open source software solution supporting data management and web-based patient-level data review for drug safety studies in the general practice research database and other health care databasesMarco Egbring, Gerd A Kullak-Ublick, Stefan Russmann
Digestive Diseases (Basel, Switzerland)|November 20, 2013
Risks of inflammatory bowel disease treatment with glucocorticosteroids and aminosalicylatesIvanka Curkovic, Marco Egbring, Gerd A Kullak-Ublick
Praxis|October 4, 2013
[Thrombocyte aggregation inhibitors: what are the risks?]Ivanka Curkovic, Marco Egbring, Gerd A Kullak-Ublick
Hip International : the Journal of Clinical and Experimental Research on Hip Pathology and Therapy|April 25, 2015
Pre-hospital medications in total hip arthroplasty: risk factors for poor outcomesMichael Dietrich, Patrick O Zingg, Marco Egbring, et al.
JMIR Cancer|March 17, 2021
Effect of Collaborative Review of Electronic Patient-Reported Outcomes for Shared Reporting in Breast Cancer Patients: Descriptive Comparative StudyAndreas Trojan, Basil Bättig, Meinrad Mannhart, et al.
European Journal of Clinical Pharmacology|March 12, 2011
Performance of different data sources in identifying adverse drug events in hospitalized patientsMarco Egbring, Elmira Far, Alexander Knuth, et al.
Journal of Medical Internet Research|September 8, 2016
A Mobile App to Stabilize Daily Functional Activity of Breast Cancer Patients in Collaboration With the Physician: A Randomized Controlled Clinical TrialMarco Egbring, Elmira Far, Malgorzata Roos, et al.
European Journal of Clinical Pharmacology|March 1, 2012
Comparative evaluation of three clinical decision support systems: prospective screening for medication errors in 100 medical inpatientsDaniela Fritz, Alessandro Ceschi, Ivanka Curkovic, et al.
BMC Pharmacology & Toxicology|September 7, 2012
Validation of a transparent decision model to rate drug interactionsElmira Far, Ivanka Curkovic, Kelly Byrne, et al.
The Annals of Pharmacotherapy|May 12, 2018
Analysis of Drug-Drug Interactions in Swiss Claims Data Using Tizanidine and Ciprofloxacin as a Prototypical Contraindicated CombinationAnnika M Jödicke, Ivanka Curkovic, Urs Zellweger, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Pharmacoepidemiology and Drug Safety|September 25, 2009
Phynx: an open source software solution supporting data management and web-based patient-level data review for drug safety studies in the general practice research database and other health care databasesMarco Egbring, Gerd A Kullak-Ublick, Stefan Russmann
Digestive Diseases (Basel, Switzerland)|November 20, 2013
Risks of inflammatory bowel disease treatment with glucocorticosteroids and aminosalicylatesIvanka Curkovic, Marco Egbring, Gerd A Kullak-Ublick
Praxis|October 4, 2013
[Thrombocyte aggregation inhibitors: what are the risks?]Ivanka Curkovic, Marco Egbring, Gerd A Kullak-Ublick
Hip International : the Journal of Clinical and Experimental Research on Hip Pathology and Therapy|April 25, 2015
Pre-hospital medications in total hip arthroplasty: risk factors for poor outcomesMichael Dietrich, Patrick O Zingg, Marco Egbring, et al.
JMIR Cancer|March 17, 2021
Effect of Collaborative Review of Electronic Patient-Reported Outcomes for Shared Reporting in Breast Cancer Patients: Descriptive Comparative StudyAndreas Trojan, Basil Bättig, Meinrad Mannhart, et al.
European Journal of Clinical Pharmacology|March 12, 2011
Performance of different data sources in identifying adverse drug events in hospitalized patientsMarco Egbring, Elmira Far, Alexander Knuth, et al.
Journal of Medical Internet Research|September 8, 2016
A Mobile App to Stabilize Daily Functional Activity of Breast Cancer Patients in Collaboration With the Physician: A Randomized Controlled Clinical TrialMarco Egbring, Elmira Far, Malgorzata Roos, et al.
European Journal of Clinical Pharmacology|March 1, 2012
Comparative evaluation of three clinical decision support systems: prospective screening for medication errors in 100 medical inpatientsDaniela Fritz, Alessandro Ceschi, Ivanka Curkovic, et al.
BMC Pharmacology & Toxicology|September 7, 2012
Validation of a transparent decision model to rate drug interactionsElmira Far, Ivanka Curkovic, Kelly Byrne, et al.
The Annals of Pharmacotherapy|May 12, 2018
Analysis of Drug-Drug Interactions in Swiss Claims Data Using Tizanidine and Ciprofloxacin as a Prototypical Contraindicated CombinationAnnika M Jödicke, Ivanka Curkovic, Urs Zellweger, et al.
Pageof 2